サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1421495

アジア太平洋の心臓AIモニタリングおよび診断市場：分析と予測（2023年～2032年）

Asia-Pacific Cardiac AI Monitoring and Diagnostics Market: Analysis and Forecast, 2023-2032
出版日: | 発行: BIS Research | ページ情報: 英文 135 Pages | 納期: 1～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
アジア太平洋の心臓AIモニタリングおよび診断市場：分析と予測（2023年～2032年）
出版日: 2024年02月07日
発行: BIS Research
ページ情報: 英文 135 Pages
納期: 1～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の心臓AIモニタリングおよび診断の市場規模は、2023年に2億40万米ドルとなりました。

同市場は、2032年には21億5,460万米ドルに達すると予測され、予測期間の2023年～2032年のCAGRは30.20%になるとみられています。心臓AIモニタリングおよび診断市場の成長は、心血管疾患の蔓延、ヘルスケアにおけるAIに対する政府の支援、心臓病学に特化したAI研究の増加、AI心臓デバイスの規制承認の増加、AI心臓診断技術の進歩によってもたらされます。

主要市場統計
予測期間 2023年～2032年
2023年の評価 2億40万米ドル
2032年予測 21億5,460万米ドル
CAGR 30.2%

アジア太平洋の心臓AIモニタリングおよび診断市場は、いくつかの重要な要因によって大きな成長を遂げています。この地域は、人口の高齢化と糖尿病や高血圧のようなライフスタイルに関連した危険因子の有病率の増加によって、心血管疾患の高い負担に直面しています。このため、高度な診断・モニタリングツールに対する需要が高まっています。アジア太平洋全域の政府は、ヘルスケアにおけるAIの可能性をますます認識するようになっており、AI技術への支援政策と投資につながっています。さらに、この地域では、心臓病学におけるAIを含むヘルスケア技術研究が急増しており、高度な診断がより身近で効率的になっています。さらに、AIベースの心臓診断機器に対する規制当局の承認件数の増加は、その有効性と安全性に対する信頼の高まりを反映しています。AIの技術的進歩は心臓診断の精度と正確性を高め、この地域の多様で拡大するヘルスケアニーズに対応しています。

当レポートでは、アジア太平洋の心臓AIモニタリングおよび診断市場について調査し、市場の概要とともに、製品別、タイプ別、用途別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

  • 市場の見通し

第2章 業界の展望

  • 主要な動向
  • 機会の評価
  • 規制の枠組み
  • 特許分析
  • ビジネスモデル
  • ケーススタディ
  • 進行中の臨床試験
  • 資金調達シナリオ
  • エンドユーザーの認識
  • 新規参入企業の参入障壁

第3章 COVID-19の影響

第4章 地域

  • アジア太平洋の心臓AIモニタリングおよび診断市場
    • 主な調査結果と機会の評価
    • デジタルの導入
    • 市場力学
    • 市場規模と予測

第5章 市場-競合ベンチマーキングと企業プロファイル

  • 心臓AIモニタリングと診断分野における活躍企業のエコシステム
  • 主要な戦略と展開
    • 規制および法的活動
  • 企業プロファイル
    • Canon Inc.
図表

List of Figures

  • Figure 1: AI in Cardiac Monitoring and Diagnosis
  • Figure 2: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 3: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Market Dynamics
  • Figure 4: Key Trends in the Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
  • Figure 5: Entry Barriers for New Entrants
  • Figure 6: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Product), 2022 and 2032
  • Figure 7: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Type), 2022 and 2032
  • Figure 8: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Application), 2022 and 2032
  • Figure 9: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by End Users), 2022 and 2032
  • Figure 10: Key Developments and Strategies Analysis, January 2020-June 2023
  • Figure 11: Cardiac AI Monitoring and Diagnostics Market: Research Methodology
  • Figure 12: Primary Research Methodology
  • Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 14: Top-Down Approach (Segment-Wise Analysis)
  • Figure 15: Overview of the Role of AI in Cardiology
  • Figure 16: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Size and Growth Potential, $Million, 2022-2032
  • Figure 17: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Key Trends
  • Figure 18: Potential of AI for Processing Patient's Own Data
  • Figure 19: Advantages of AI-Enabled Wearable Sensors for Cardiac Monitoring
  • Figure 20: Cardiac AI Monitoring and Diagnostics Market, Key Trends, Opportunity Assessment, 2023-2032
  • Figure 21: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Country), January 2018-June 2023
  • Figure 22: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Year), January 2018-June 2023
  • Figure 23: Different Types of Business Models in the AI in Healthcare Scenario
  • Figure 24: Subscription-Based Model the Market is Shifting Towards
  • Figure 25: Partners of Ultromics Limited
  • Figure 26: Ultromics Limited:Awards and Recognitions
  • Figure 27: The CorVista System
  • Figure 28: Cardiac AI Monitoring and Diagnostics Market, Quarterly Analysis of Funding Scenario, January 2020-June 2023
  • Figure 29: Cardiac AI Monitoring and Diagnostics Market, End User Perceptions
  • Figure 30: Entry Barriers for New Entrants
  • Figure 31: Recommendations to Tackle the Entry Barriers
  • Figure 32: Tools and Technologies of AI for Cardiology During COVID-19
  • Figure 33: Cardiac AI Monitoring and Diagnostics Market Share (by Region), 2022-2032
  • Figure 34: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
  • Figure 35: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 36: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 37: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 38: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 39: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 40: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 41: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
  • Figure 42: Japan Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 43: Japan Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 44: Japan Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 45: Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 46: Japan Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 47: Japan Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 48: China Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 49: China Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 50: China Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 51: China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 52: China Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 53: China Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 54: India Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 55: India Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 56: India Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 57: India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 58: India Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 59: India Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 60: Australia Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 61: Australia Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 62: Australia Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 63: Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 64: Australia Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 65: Australia Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 66: South Korea Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 67: South Korea Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 68: South Korea Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 69: South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 70: South Korea Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 71: South Korea Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 72: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 73: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 74: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 75: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 76: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 77: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 78: Share of Key Developments and Strategies, January 2019-June 2023
  • Figure 79: Regulatory and Legal Activities (by Company), January 2019-June 2023
  • Figure 80: Canon Inc.: Overall Product Portfolio
  • Figure 81: Canon Inc.: Overall Financials, $Million, 2020-2022
  • Figure 82: Canon Inc.: Net Revenue (by Segment), $Million, 2020-2021
  • Figure 83: Canon Inc.: Net Revenue (by Segment), $Million, 2022
  • Figure 84: Canon Inc.: Net Revenue (by Region), $Million, 2020-2022
  • Figure 85: Canon Inc.: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Regulatory Framework
  • Table 2: Key Questions Answered in the Report
  • Table 3: Startups Entering the Market
  • Table 4: Regulatory Framework of Different Countries
  • Table 5: Cardiac AI Monitoring and Diagnostics Market, Awaited Technological Developments
  • Table 6: CorVista Health Inc. Publications
  • Table 7: Cardiac AI Monitoring and Diagnostics Market, Ongoing Clinical Trials
  • Table 8: Investments and Fundings in Cardiac AI Monitoring and Diagnostics Market
  • Table 9: Applications of Artificial Intelligence in Cardiology During COVID-19 Pandemic
  • Table 10: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
  • Table 11: Total Deaths and CVD Death Rates of Men/Women in 2018 in Japan (Per 100,000 of the Population)
  • Table 12: Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
目次
Product Code: BHD1841SS

“The Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Expected to Reach $2,154.6 Million by 2032.”

Introduction to Asia-Pacific Cardiac AI Monitoring and Diagnostics Market

The Asia-Pacific cardiac AI monitoring and diagnostics market was valued at $200.4 million in 2023 and is anticipated to reach $2,154.6 million by 2032, witnessing a CAGR of 30.20% during the forecast period 2023-2032. Growth in the cardiac AI monitoring and diagnostics market is driven by widespread cardiovascular diseases, government support for AI in healthcare, increasing cardiology-focused AI research, more regulatory approvals for AI cardiac devices, and advances in AI cardiac diagnostics technology.

KEY MARKET STATISTICS
Forecast Period2023 - 2032
2023 Evaluation$200.4 Million
2032 Forecast$2,154.6 Million
CAGR30.2%

Market Introduction

The Asia-Pacific (APAC) market for cardiac AI monitoring and diagnostics is witnessing significant growth, driven by several key factors. The region faces a high burden of cardiovascular diseases, fueled by aging populations and increasing prevalence of lifestyle-related risk factors like diabetes and hypertension. This has heightened the demand for advanced diagnostic and monitoring tools. Governments across APAC are increasingly recognizing the potential of AI in healthcare, leading to supportive policies and investments in AI technology. Additionally, the region is seeing a surge in healthcare technology research, including AI applications in cardiology, making advanced diagnostics more accessible and efficient. Furthermore, the increasing number of regulatory approvals for AI-based cardiac diagnostic devices reflects a growing trust in their effectiveness and safety. Technological advancements in AI are enhancing the precision and accuracy of cardiac diagnostics, catering to the region's diverse and expanding healthcare needs.

Market Segmentation:

Segmentation 1: by Product

  • Software
  • Hardware

Segmentation 2: by Type

  • Cardiac Diagnostics
    • Imaging
    • ECG-Based
    • Others
  • Cardiac Monitoring

Segmentation 3: by Application

  • Ischemic Heart Disease/CAD
  • Cardiac Arrhythmias
  • Ischemic Stroke
  • Others

Segmentation 4: by End User

  • Hospitals
  • Diagnostic Centers
  • Other End Users

Segmentation 5: by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The APAC cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Table of Contents

Executive Summary

1. Market

  • 1.1. Market Outlook
    • 1.1.1. Product Definition
    • 1.1.2. Inclusion Criteria
    • 1.1.3. Exclusion Criteria
    • 1.1.4. Overview
      • 1.1.4.1. Market Size and Growth Potential

2. Industry Outlook

  • 2.1. Key Trends
    • 2.1.1. Rising Number of Startups in the Market
    • 2.1.2. Increased Awareness Regarding Preventative Measures and Personalized Treatment
    • 2.1.3. Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
  • 2.2. Opportunity Assessment
  • 2.3. Regulatory Framework
    • 2.3.1. Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
    • 2.3.2. Regulatory Framework in Japan
    • 2.3.3. Regulatory Framework in China
  • 2.4. Patent Analysis
    • 2.4.1. Awaited Technological Developments
      • 2.4.1.1. Patent Analysis (by Country)
      • 2.4.1.2. Patent Analysis (by Year)
  • 2.5. Business Models
  • 2.6. Case Studies
    • 2.6.1. Case Study 1: Ultromics Limited
      • 2.6.1.1. The EchoGo System
        • 2.6.1.1.1. Developement
        • 2.6.1.1.2. Use Case and Reliability
      • 2.6.1.2. A Success Story
      • 2.6.1.3. Partners and Recognitions
    • 2.6.2. Case Study 2: CorVista Health, Inc.
      • 2.6.2.1. The CorVista System
      • 2.6.2.2. A Success Story
  • 2.7. Ongoing Clinical Trials
  • 2.8. Funding Scenario
  • 2.9. End User Perception
  • 2.1. Entry Barriers for New Entrants

3. Impact of COVID-19

  • 3.1. Impact on the Overall Market
  • 3.2. Pre-COVID-19 Scenario
  • 3.3. During COVID-19 Scenario
  • 3.4. Post COVID-19 Scenario

4. Regions

  • 4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
    • 4.1.1. Key Findings and Opportunity Assessment
    • 4.1.2. Digital Adoption
    • 4.1.3. Market Dynamics
      • 4.1.3.1. Impact Analysis
    • 4.1.4. Market Sizing and Forecast
      • 4.1.4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
      • 4.1.4.2. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.2.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
      • 4.1.4.3. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
      • 4.1.4.4. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 4.1.4.5. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country)
        • 4.1.4.5.1. Japan
          • 4.1.4.5.1.1. Market Dynamics
          • 4.1.4.5.1.2. Market Size and Forecast
          • 4.1.4.5.1.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.1.2.2. Japan Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.1.2.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.1.2.3. Japan Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.1.2.4. Japan Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.2. China
          • 4.1.4.5.2.1. Market Dynamics
          • 4.1.4.5.2.2. Market Size and Forecast
          • 4.1.4.5.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.2.2.2. China Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.2.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.2.2.3. China Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.2.2.4. China Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.3. India
          • 4.1.4.5.3.1. Market Dynamics
          • 4.1.4.5.3.2. Market Size and Forecast
          • 4.1.4.5.3.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.3.2.2. India Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.3.2.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.3.2.3. India Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.3.2.4. India Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.4. Australia
          • 4.1.4.5.4.1. Market Dynamics
          • 4.1.4.5.4.2. Market Size and Forecast
          • 4.1.4.5.4.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.4.2.2. Australia Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.4.2.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.4.2.3. Australia Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.4.2.4. Australia Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.5. South Korea
          • 4.1.4.5.5.1. Market Dynamics
          • 4.1.4.5.5.2. Market Size and Forecast
          • 4.1.4.5.5.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.5.2.2. South Korea Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.5.2.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.5.2.3. South Korea Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.5.2.4. South Korea Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.6. Rest-of-Asia-Pacific
          • 4.1.4.5.6.1. Market Size and Forecast
          • 4.1.4.5.6.1.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.6.1.2. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.6.1.2.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.6.1.3. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.6.1.4. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)

5. Markets - Competitive Benchmarking & Company Profiles

  • 5.1. Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
  • 5.2. Key Strategies and Developments
    • 5.2.1. Regulatory and Legal Activities
  • 5.3. Company Profiles
    • 5.3.1. Canon Inc.
      • 5.3.1.1. Company Overview
      • 5.3.1.2. Role of Canon Inc. in the Cardiac AI Monitoring and Diagnostics Market
      • 5.3.1.3. Financials
      • 5.3.1.4. Analyst Perception